Since acceptance of our paper, "Serum Glutathione Reductase and Cystic Fibrosis" (I), we have obtained additional data which support the specificity of the reported serum glutathione reductase (GR) changes in cystic fibrosis (CF). Serum was obtained from 10 additional C F individuals and 10 sex-and approximately agematched controls. Serum from each individual was assayed for G R , lactate dehydrogenase (LDH), and glutamic-pyruvic transaminase (GPT). Raised serum levels of the latter two enzymes reflect tissue damage. As in previous series, mean G R in C F was 20% greater than in controls (Y < 0.005). No difference was found between C F and controls for either LDH or G P T (P > 0.40). The following correlation coefficients were estimated: (controls: GR-LDH (0.86); GR-GPT (0.55)); (CF: GR-LDH (-0.06); GR-GPT (-0.15)). It appears that some underlying process or processes such as leakage into serum from cellular damage as reflected in raised LDH and G P T might lead to raised G R as demonstrated by positive correlations in controls. For example, in one non-CF control subject in whom LDH and GPT values were abnormally high, G R was greater than the C F mean.
In no C F subject was serum LDH abnormally raised. In two CF subjects in whom G P T values exceeded normal values, G R was no different from the C F mean G R . The absence of a positive correlation between these enzymes and G R in the C F sample as well as normal values for LDH and G P T in C F suggests that the raised serum G R in C F is not attributable to tissue leakage from damaged cells secondary to the disease.
